Synergic effect of combined melatonin and tofacitinib on ameliorating dextran sulfate sodium-induced colitis in rat---role of JAKs/STAT, cell-stress signaling, and inflammatory-immune reaction.

IF 1.3 Q4 IMMUNOLOGY
American journal of clinical and experimental immunology Pub Date : 2025-08-15 eCollection Date: 2025-01-01 DOI:10.62347/FXYY2658
Chia-Lo Chang, Chih-Hung Chen, Yi-Ling Chen, John Y Chiang, Yi-Ting Wang, Chi-Ruei Huang, Hong-Hwa Chen, Hon-Kan Yip
{"title":"Synergic effect of combined melatonin and tofacitinib on ameliorating dextran sulfate sodium-induced colitis in rat---role of JAKs/STAT, cell-stress signaling, and inflammatory-immune reaction.","authors":"Chia-Lo Chang, Chih-Hung Chen, Yi-Ling Chen, John Y Chiang, Yi-Ting Wang, Chi-Ruei Huang, Hong-Hwa Chen, Hon-Kan Yip","doi":"10.62347/FXYY2658","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study investigated whether the combined treatment of melatonin and tofacitinib offers enhanced protection against dextran sulfate sodium-induced acute colitis (AC) in rats. Using CCD-18Co fibroblasts and a rat colitis model, we assessed the anti-inflammatory, anti-apoptotic, and immunomodulatory effects of the combination therapy.</p><p><strong>Methods: </strong>CCD-18Co cells were grouped as A1 (CCD-18Co), A2 (CCD-18Co + lipopolysaccharide (LPS)), A3 (CCD-18Co + LPS + Melatonin), A4 (CCD-18Co + LPS + Tofacitinib), or A5 (CCD-18Co + LPS + melatonin + tofacitinib). Sprague-Dawley rats were categorized into groups 1 (normal control), 2 (AC), 3 (AC + melatonin), 4 (AC + tofacitinib), and 5 (AC + melatonin + tofacitinib), and the colons were harvested 14 days after AC induction.</p><p><strong>Key findings: </strong>Cell viability at time points of 24, 48, and 72 h was the highest in A1, lowest in A2, and progressively increased from A3 to A5 (all P < 0.0001). The protein expression levels of inflammatory, DNA-damaged, and autophagic (ratio of LC3-BII to LC3-BI) biomarkers displayed identical patterns of apoptosis among the groups (all P < 0.0001). Additionally, the blood stool, colon leakage, and colon injury scores were the lowest in group 1, highest in group 2, and significantly progressively reduced from groups 3 to 5 (all P < 0.0001). The protein expression of the Janus kinase family-signal transducer and activator of transcriptions/cell-stress signaling, inflammation, oxidative stress, DNA-damaged, apoptotic biomarkers, and cellular expression of immune and inflammatory factors exhibited an identical pattern of colon injury scores among the groups.</p><p><strong>Conclusions: </strong>Combined melatonin-tofacitinib treatment effectively protected the colon against dextran sulfate sodium-induced damage, mainly through the suppression of Janus kinase family-signal transducer and activator of transcriptions/cell-stress signaling, inflammation, and oxidative stress.</p>","PeriodicalId":72163,"journal":{"name":"American journal of clinical and experimental immunology","volume":"14 4","pages":"185-203"},"PeriodicalIF":1.3000,"publicationDate":"2025-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12444406/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of clinical and experimental immunology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.62347/FXYY2658","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: This study investigated whether the combined treatment of melatonin and tofacitinib offers enhanced protection against dextran sulfate sodium-induced acute colitis (AC) in rats. Using CCD-18Co fibroblasts and a rat colitis model, we assessed the anti-inflammatory, anti-apoptotic, and immunomodulatory effects of the combination therapy.

Methods: CCD-18Co cells were grouped as A1 (CCD-18Co), A2 (CCD-18Co + lipopolysaccharide (LPS)), A3 (CCD-18Co + LPS + Melatonin), A4 (CCD-18Co + LPS + Tofacitinib), or A5 (CCD-18Co + LPS + melatonin + tofacitinib). Sprague-Dawley rats were categorized into groups 1 (normal control), 2 (AC), 3 (AC + melatonin), 4 (AC + tofacitinib), and 5 (AC + melatonin + tofacitinib), and the colons were harvested 14 days after AC induction.

Key findings: Cell viability at time points of 24, 48, and 72 h was the highest in A1, lowest in A2, and progressively increased from A3 to A5 (all P < 0.0001). The protein expression levels of inflammatory, DNA-damaged, and autophagic (ratio of LC3-BII to LC3-BI) biomarkers displayed identical patterns of apoptosis among the groups (all P < 0.0001). Additionally, the blood stool, colon leakage, and colon injury scores were the lowest in group 1, highest in group 2, and significantly progressively reduced from groups 3 to 5 (all P < 0.0001). The protein expression of the Janus kinase family-signal transducer and activator of transcriptions/cell-stress signaling, inflammation, oxidative stress, DNA-damaged, apoptotic biomarkers, and cellular expression of immune and inflammatory factors exhibited an identical pattern of colon injury scores among the groups.

Conclusions: Combined melatonin-tofacitinib treatment effectively protected the colon against dextran sulfate sodium-induced damage, mainly through the suppression of Janus kinase family-signal transducer and activator of transcriptions/cell-stress signaling, inflammation, and oxidative stress.

褪黑素联合托法替尼对大鼠葡聚糖硫酸钠诱导的结肠炎的协同作用——JAKs/STAT、细胞应激信号和炎症免疫反应的作用
背景:本研究探讨褪黑素和托法替尼联合治疗是否对大鼠葡聚糖硫酸钠诱导的急性结肠炎(AC)有增强的保护作用。利用CCD-18Co成纤维细胞和大鼠结肠炎模型,我们评估了联合治疗的抗炎、抗凋亡和免疫调节作用。方法:将CCD-18Co细胞分为A1 (CCD-18Co)、A2 (CCD-18Co +脂多糖(LPS))、A3 (CCD-18Co +脂多糖+褪黑素)、A4 (CCD-18Co +脂多糖+托法替尼)、A5 (CCD-18Co +脂多糖+褪黑素+托法替尼)。将Sprague-Dawley大鼠分为1组(正常对照)、2组(AC)、3组(AC +褪黑素)、4组(AC +褪黑素+托法替尼)和5组(AC +褪黑素+托法替尼),在AC诱导后第14天收集结肠。关键发现:细胞活力在24、48和72 h时A1最高,A2最低,从A3到A5逐渐增加(均P < 0.0001)。炎症、dna损伤和自噬(LC3-BII与LC3-BI的比值)生物标志物的蛋白表达水平在各组间显示出相同的凋亡模式(均P < 0.0001)。血便、结肠漏、结肠损伤评分以1组最低,2组最高,3 ~ 5组逐渐显著降低(均P < 0.0001)。Janus激酶家族的蛋白表达——转录/细胞应激信号的信号转换器和激活器、炎症、氧化应激、dna损伤、凋亡生物标志物以及免疫和炎症因子的细胞表达在各组中表现出相同的结肠损伤评分模式。结论:褪黑激素-托法替尼联合治疗可有效保护结肠免受葡聚糖硫酸盐钠诱导的损伤,其机制主要是通过抑制Janus激酶家族信号转导和转录/细胞应激信号激活因子、炎症和氧化应激。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信